Ann Little: Prof Giunti, congratulations for winning the 2016 EFNA Neurology Advocacy Award for Health Professional. Your work in advocating for ataxia patients is highly commended. Could you briefly explain to us the main concept behind your Ataxia Centre in London, which has been put forward as an example of best clinical practice? Paola Giunti: I established the Specialist Ataxia Centre in London over 10 years ago to address my patients’ needs. The ataxias are rare complex disorders, the majority of which are truly multi-systemic with a number of extra-cerebellar symptoms requiring multi-specialist care.

by Prof. Dr. Claudia Sommer Teaching courses are designed to convey knowledge on a topical area within Neurology, with the ultimate aim to help the attendees to better understand this area, so that with this enhanced knowledge they will improve… Continue Reading

By Anja Gijtenbeek, on behalf of the Dutch Society of Neuro-Oncology The diagnosis and care of patients with neurological malignancies or neurological complications of systemic cancer pose many challenges, and requires multidisciplinary expertise. Nearly 25 years ago, two founding fathers… Continue Reading

David B. Vodušek (DV): Can you kindly illustrate how the idea of creating NBCs came about and what their intrinsic value is to EBC? F. Destrebecq (FD): The EBC has been founded to catch the ear of the EU decision makers. However, soon it became clear that by focusing only on Brussels, the EBC would not be able to achieve its full potential of influence.

As in the previous year, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Amsterdam 2017. Please find their answers below!

Abstract Submission Deadline is January 13, 2017!  In order to submit an abstract, please log in/register on www.ean.org/amsterdam2017 and go to your MyEAN area. There you can update your personal data and also find a link to the abstract submission… Continue Reading

For January 2017, we have selected: Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière’s disease: a randomized double-blind, comparative effectiveness trial. Lancet Neurol 2016;388:2753-2762. Disabling vertigo attacks and hearing loss are characteristics of Ménière’s disease. In patients with severe and frequent vertigo spells, intratympanic injections of gentamicin have proved to be effective, but at the price of permanent vestibular damage and hearing loss.

Kazakhstan, officially the Republic of Kazakhstan (Kazakh: Қазақстан Республикасы), is located at the center of the Eurasia continent. On the north and west sides, Kazakhstan shares borders with Russia, on the east with China, and on the south with Kyrgyzstan, Uzbekistan, and Turkmenistan. Kazakhstan is a huge country, being at the 9th place in the world for its size.

The objective of the “Clinical Fellowship Programme” is to provide a well- defined clinical observational experience in a department with recognised expertise in a specific field.
With this programme, neurologists that are still in the process of training, or recently… Continue Reading

Do not miss the highly popular Reviews and Invited Reviews published regularly in the European Journal of Neurology.  Herewith the latest Reviews:

Dear EAN members, dear readers, as EANpages Editor, it is my privilege to send you a few lines at the end of this 2016, which has been a very important and special year for EANpages. Together with the launch of… Continue Reading